NCT03128762View on ClinicalTrials.gov

Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

June 25, 2014

Primary Completion Date

April 14, 2015

Study Completion Date

June 23, 2015

Conditions
Asthma
Interventions
BIOLOGICAL

ILC2 levels in blood

The levels of circulating ILC2 cells relative to other lymphocytes will be determined via flow cytometry

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03128762 - Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study | Biotech Hunter | Biotech Hunter